Preterm delivery

Lancet

Volumn 360, Issue 9344, 2002, Pages 1489-1497

  Slattery, Michael M ^a   Morrison, John J ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ATOSIBAN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; CALCITONIN GENE RELATED PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CHORIONIC GONADOTROPIN; CLINDAMYCIN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; GLUCOCORTICOID; GLYCERYL TRINITRATE; INDOMETACIN; MAGNESIUM SULFATE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHOTRANSFERASE INHIBITOR; POTASSIUM CHANNEL STIMULATING AGENT; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; UTERUS SPASMOLYTIC AGENT; VASOACTIVE INTESTINAL POLYPEPTIDE;

BRAIN DISEASE; CHILDBIRTH; COST EFFECTIVENESS ANALYSIS; DISABILITY; DRUG EFFICACY; DRUG RESPONSE; ETHNIC GROUP; GENITAL TRACT INFECTION; HUMAN; INTRAUTERINE INFECTION; LABOR; LABOR INDUCTION; LUNG DISEASE; MATERNAL AGE; MORBIDITY; MORTALITY; MULTIPLE PREGNANCY; PARITY; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROPHYLAXIS; RACE DIFFERENCE; REPRODUCTIVE HEALTH; REVIEW; RISK FACTOR; SOCIAL STATUS; SOCIAL SUPPORT; SUBSTANCE ABUSE; SURVIVAL; TOCOLYSIS; TREATMENT OUTCOME; UTERINE CERVIX CERCLAGE; UTERINE CERVIX INCOMPETENCE; UTERUS CONTRACTION; UTERUS RELAXATION;

EID: 0037048905     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11476-0     Document Type: Review

References (140)

1. Anon. Practice bulletin ACOG: Clinical management guidelines for obstetrician-gynecologists number 31 - Assessment of risk factors for preterm birth, Obstet Gynecol 2001; 98: 709-706.
2. Iannucci T.A., Tomich P.G., Gianopoulos J.G. Etiology and outcome of extremely low-birth-weight infants. Am J Obstet Gynecol. 174:1996;1896-1902.
3. Burke C., Morrison J.J. Perinatal factors and preterm delivery in an Irish obstetric population. J Perinat Med. 28:2000;49-53.
4. Olsen P., Laara E., Rantakillio P., et al. Epidemiology of preterm delivery in two birth cohorts with an interval of 20 years. Am J Epidemiol. 142:1995;1184-1193.
5. Mercer B.M., Goldenberg R.L., Das A., et al. The preterm prediction study: a clinical risk assessment system. Am J Obstet Gynecol. 174:1996;1885-1895.
6. Kramer M.S., Goulet L., Lydon J., et al. Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinatal Epidemiol. 15:2001;104-123.
7. Goldenberg R.L., Rouse D.J. Prevention of premature birth. N Engl J Med. 339:1998;313-320.
8. Creasy R.K. Preterm birth prevention: where are we? Am J Obstet Gynecol. 168:1993;1223-1230.
9. Morrison J.J., Rennie J.M. Clinical, scientific and ethical aspects of fetal and neonatal care at extreme preterm periods of gestation. Br J Obstet Gynaecol. 104:1997;1341-1350.
10. Demissie K., Rhoads G.G., Ananth C.V., et al. Trends in preterm birth and neonatal mortality among blacks and whites in the United States from 1989 to 1997. Am J Epidemiol. 154:2001;307-315.
11. Katz V.L., Bose C.L. Improving survival of the very premature infant. J Perinatol. 13:1993;261-265.
12. Allen M.C., Donohue P.K., Dusman A.E. The limit of viability: neonatal outcome of infants born at 22 to 25 weeks gestation. N Engl J Med. 329:1993;1597-1601.
13. Ferrara T.B., Hockstra R.E., Couser R.J., et al. Survival and follow up of infants born at 23 to 26 weeks of gestational age: effects of surfactant therapy. J Pediatr. 124:1994;119-124.
14. Holtrop P.C., Ertzbischoff L.M., Roberts C.L., Batton C.G., Lorenz R.P. Survival and short term outcome in newborns of 23 to 25 weeks gestation. Am J Obstet Gynecol. 170:1994;1266-1270.
15. Hagan R., Benninger H., Chiffings D., Evans S., French N. Very preterm birth: a regional study, part 2 - the very preterm infant. BJOG. 103:1996;239-245.
16. Rennie J.M. Perinatal management at the lower margin of viability. Arch Dis Child. 74:1996;F214-218.
17. Bohin S., Draper E.S., Field D.J. The impact of extremely immature infants on neonatal services. Arch Dis Child. 74:1996;F110-113.
18. Lefebvre F., Glorieux J., St-Laurent-Gagnon T. Neonatal survival and disability rate at age 18 months for infants born between 23 and28 weeks of gestation. Am J Obstet Gynecol. 174:1996;833-838.
19. Kilpatrick S.J., Schlueter M.A., Piecuch R., et al. Outcome of infants born at 24-26 weeks' gestation, 1: survival and cost. Obstet Gynecol. 90:1997;803-808.
20. Finnstrom O., Otterbald Olausson P., Sedin G., et al. The Swedish national prospective study on extremely low birthweight (ELBW) infants: incidence, mortality, morbidity and survival in relation to level of care. Acta Paediatr. 86:1997;503-511.
21. Wood N.S., Marlow N., Costeloe K., Gibson A.T., Wilkinson A.R. Neurological and developmental disability after extremely preterm birth. N Engl J Med. 343:2000;378-384.
22. Bunning-Pfaue F., Gallagher D., Loftus B.G. Audit of very low birth weight survival in Galway. Ir J Med Sci. 169:(suppl. 4):2000;71.
23. El-Metwally D., Vohr B., Tucker R. Survival and neonatal morbidity at the limits of viability in the mid 1990s: 22 to 25 weeks. J Pediatr. 137:2000;616-622.
24. Gardner M.O., Goldenberg R.L., Cliver S.P., et al. The origin and outcome of preterm twin pregnancies. Obstet Gynecol. 85:1995;553-557.
25. Rydhstroem H., Heraib F. Gestational duration, and fetal and infant mortality for twins vs singletons. Twin Res. 4:2001;227-231.
26. Cheung Y.B., Yip P., Karlberg J. Mortality of twins and singletons by gestational age: a varying-coefficient approach. Am J Epidemiol. 152:2000;1117-1119.
27. Pharoah P.O., Cooke T., Johnson M.A., King R., Mutch L. Epidemiology of cerebral palsy in England and Scotland, 1984-9. Arch Dis Child. 1998:1984;F21-25.
28. Hack M., Flannery D.J., Schluchter M., et al. Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med. 346:2002;149-157.
29. McCormick M.C., Richardson D.K. Premature infants grow up. N Engl J Med. 346:2002;197-198.
30. Morrison J.J. Prediction and prevention of preterm labour. Studd J.W.W., Progress in obstetrics and gynaecology. 12:1996;67-85 Churchill Livingstone, Edinburgh.
31. Mattison D.R., Damus K., Fiore E., Petrini J., Alter C. Preterm delivery: a public health perspective. Paediatr Perinatal Epidemiol. 15:2001;7-16.
32. Leung T.N., Roach V.J., Lau T.K. Incidence of preterm delivery in Hong Kong Chinese. Aust N Z J Obstet Gynaecol. 38:1998;133-137.
33. Monaghan S.C., Little R.E., Hulchiy O., Strassner H., Gladen B.C. Preterm birth in two urban areas of Ukraine. Obstet Gynecol. 95:2000;752-755.
34. Ananth C.V., Misra D.P., Demissie K., Smulian J.C. Rates of preterm delivery among Black women and White women in the United States over two decades: an age-period-cohort analysis. Am J Epidemiol. 154:2001;657-665.
35. Meis P.J., Ernest J.M., Moore M.L. Causes of low birth weights in public and private patients. Am J Obstet Gynecol. 156:1987;1165-1168.
36. Joseph K.S., Kramer M.S., Maecoux S., et al. Determinants of preterm birth rates in Canada from 19181 through 1983 and from 1992 through 1994. N Engl J Med. 339:1998;1434-1439.
37. Romero R., Athayde N., Maymon E., Pacora P., Bahado-Singh R. Premature rupture of the membranes. Reece A., Hobbins J., Medicine of the fetus and mother. 1999;1581-1625 Lippincott-Raven, Philadelphia.
38. Sawdy R.J., Bennett P.R. Recent advances in the therapeutic management of preterm labour. Curr Opin Obstet Gynecol. 11:1999;131-139.
39. McFarlane A., Cole S., Johnson A., Botting B. Epidemiology of birth before 28 weeks of gestation. Br Med Bull. 44:1988;861-891.
40. Koupilova I., Vagero D., Leon D.A., et al. Social variation in size at birth and preterm delivery in the Czech Republic and Sweden, 1989-91. Paediatr Perinatal Epidemiol. 12:1998;7-24.
41. Mueller-Heubach E., Reddick D., Barnett B., Bente R. Preterm birth prevention: evaluation of a prospective controlled randomized trial. Am J Obstet Gynecol. 160:1989;1172-1178.
42. Collaborative Group on Preterm Birth Prevention. Multicenter randomized, controlled trial of a preterm birth prevention program. Am J Obstet Gynecol. 169:1993;352-366.
43. Schieve L.A., Handler A. Preterm delivery and perinatal death among black and white infants in a Chicago-area perinatal registry. Obstet Gynecol. 88:1996;356-363.
44. McGrady G.A., Sung J.F., Rowley D.L., Hogue C.J. Preterm delivery and low birth weight among first-born infants of black and white college graduates. Am J Epidemiol. 136:1992;266-276.
45. US Department of Health and Social Services. Healthy People 2010. Washington: US Department of Health and Social Services, 2000.
46. Ventura SJ, Martin JA, Curtin SC. Mathews TJ. Births: Final data for 1997. National Vital Statistics Report, vol 47, No 18. Hyattsville: National Center for Health Statistics, 1999.
47. Glinianaia S.V., Rankin J., Renwick M. Time trends in twin perinatal mortality in northern England, 1982-94. Twin Res. 1:1998;189-195.
48. Health Canada. Canadian Perinatal Health Report. Ottawa: Minister of Public Works and Government Services Canada, 2000.
49. Joseph K.S., Allen A.C., Dodds L., Vincer M.J., Armson B.A. Causes and consequences of recent increases in preterm birth among twins. Obstet Gynecol. 98:2001;57-64.
50. Fraser A.M., Brockert J.E., Ward R.H. Association of young maternal age with adverse reproductive outcomes. N Engl J Med. 332:1995;1113-1117.
51. Smith G.C., Pell J.P. Teenage pregnancy and risk of adverse perinatal outcomes associated with first and second births: population based retrospective cohort study. BMJ. 323:2001;476-480.
52. Carr-Hill R.A., Hall M.H. The repetition of spontaneous preterm labour. BJOG. 92:1985;921-928.
53. Kristensen J., Langhoff-Roos J., Kristensen F.B. Implications of idiopathic preterm delivery for previous and subsequent pregnancies. Obstet Gynecol. 86:1995;800-804.
54. Bakketeig L.S., Hoffman H.J., Harley E.E. The tendency to repeat gestational age and birth weight in successive births. BMJ. 135:1979;1086-1103.
55. Goldenberg R.L., Mayberry S.K., Copper R.L., Dubard M.B., Hauth J.C. Pregnancy outcome following a second-trimester loss. Obstet Gynecol. 81:1993;444-446.
56. Zhou W., Sorensen H.T., Olsen J. Induced abortion and subsequent pregnancy duration. Obstet Gynecol. 94:1999;948-953.
57. Lumley J. The epidemiology of preterm birth. Baillieres Clin Obstet Gynaecol. 7:1993;477-498.
58. Fisch B., Harel L., Kaplan B., et al. Neonatal assessment of babies conceived by in vitro fertilization. J Perinatol. 17:1997;473-476.
59. Perri T., Chen R., Yoeli R., et al. Are singleton assisted reproductive technology pregnancies at risk of prematurity? J Assist Reprod Genet. 18:2001;245-249.
60. Abdalla H.I., Billett A., Kan A.K., et al. Obstetric outcome in 232 ovum donation pregnancies. BJOG. 105:1998;332-337.
61. Soderstrom-Anttila V., Sajaniemi N., Tiitinen A., Hovatta O. Health and development of children born after oocyte donation compared with that of those born after in vitro fertilization, and parents' attitudes regarding secrecy. Hum Reprod. 13:1998;2009-2015.
62. Bernasko J., Lynch L., Lapinski R., Berkowitz R.L. Twin pregnancies conceived by assisted reproductive techniques: maternal and neonatal outcomes. Obstet Gynecol. 89:1997;368-372.
63. Hansen M., Kurinezuk J.J., Bower C., Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med. 346:2002;725-730.
64. Boer K., Smit B.J., van Huis A.M., Hogerzeil H.V. Substance use in pregnancy: do we care? Acta Paediatr Suppl. 404:1994;65-71.
65. Cherukuri R., Minkoff H., Feldman J., Parekh A., Glass L. A cohort study of alkaloidal cocaine. Obstet Gynecol. 72:1988;147-151.
66. Neerhof M.G., MacGregor S.N., Retzky S.S., Sullivan T.P. Cocaine abuse during pregnancy: peripartum prevalence and perinatal outcome. Am J Obstet Gynecol. 161:1989;633-638.
67. Handler A., Kistin N., Davis F., Ferre C. Cocaine use during pregnancy: perinatal outcomes. Am J Epidemiol. 133:1991;818-821.
68. Dinsmoor M.J., Irons S.J., Christmas J.T. Premature rupture of the membranes associated with recent cocaine use. Am J Obstet Gynecol. 171:1994;305-308.
69. Offidani C., Pomini F., Caruso A., et al. Cocaine during pregnancy: a critical review of the literature. Minerva Ginecol. 47:1995;381-390.
70. Shiono P.H., Klebanoff M.A., Nugent R.P., et al. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol. 172:1995;19-27.
71. Miller J.M., Boudreaux M.C. A study of antenatal cocaine use: chaos in action. Am J Obstet Gynecol. 180:1999;1427-1431.
72. Hatch E.E., Bracken M.B. Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol. 124:1986;986-993.
73. Fergusson D.M., Horwood J.L., Northstone K. Maternal use of cannabis and pregnancy outcome. BJOG. 109:2002;21-27.
74. Kramer M.S. Attributable causes of low birth weight. Battaglia F., Falkner F., Garza C., et al. Maternal and extrauterine nutritional factors: their influence on fetal and infant growth. 1996;349-357 Ediciones Ergon, Madrid.
75. Golding J. Reproduction and caffeine consumption: a literature review. Early Hum Dev. 43:1995;1-14.
76. Fan Y.D., Pastorek J.G., Miller J.M., Mulvey J. Acute pyelonephritis in pregnancy. Am J Perinatol. 4:1987;324-326.
77. Madinger N.E., Greenspoon J.S., Ellrodt A.G. Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? Am J Obstet Gynecol. 161:1989;657-662.
78. Sebire N.J. Choriodecidual inflammatory syndrome (CoDIS) is the leading, and under recognized, cause of early preterm delivery and second trimester miscarriage. Med Hypotheses. 56:2001;497-500.
79. Romero R., Gomez R., Chaiworapongsa T., et al. The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol. 15:(suppl. 2):2001;41-56.
80. Romero R., Mazor M. Infection and preterm labor. Clin Obstet Gynecol. 31:1988;553-584.
81. Krohn M.A., Hillier S.L., Nugent R.P., et al. The genital flora of women with intra-amniotic infection. J Infect Dis. 171:1995;1457-1480.
82. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med. 342:2000;1500-1507.
83. Hay P.E., Lamont R.F., Taylor-Robinson D., et al. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ. 308:1994;295-298.
84. Hillier S.L., Krohn M.A., Cassen E., et al. The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin Infect Dis. 20:(suppl. 2):1994;S276-278.
85. Romero R., Shamma F., Avila C., et al. Infection and labor, VI: prevalence, microbiology, and clinical significance of intra-amniotic infection in twin gestations with preterm labor. Am J Obstet Gynecol. 163:1990;757-761.
86. Pao C.C., Kao S.M., Wang H.C., Lee C.C. Intra-amniotic detection of Chlamydia trachomatis deoxyribonucleic acid sequences by polymerase chain reaction. Am J Obstet Gynecol. 164:1991;1295-1299.
87. Jalava J., Mantymaa M.L., Ekbald U. Bacterial 16S rDNA polymerase chain reaction in the detection of intra-amniotic infection. BJOG. 103:1996;664-669.
88. Egarter C.H., Husslein P. Biochemistry of myometrial contractility. Baillieres Clin Obstet Gynaecol. 6:1992;755-769.
89. Thornton S., Gillespie J.I. Biochemistry of uterine contractions. Contemp Rev Obstet Gynaecol. 4:1992;121-126.
90. Wray S. Uterine contraction and physiological mechanisms of modulation. Am J Physiol. 264:1993;C1-18.
91. Morrison J.J., Dearn R., Smith S.K., Ahmed A. Activation of protein kinase C is required for oxytocin-induced contractility in human pregnant myometrium. Hum Reprod. 11:1996;2285-2290.
92. Ekerhovd E., Weidegard B., Brannstrom M., Norstrom A. Nitric oxide-mediated effects on myometrial contractility at term during prelabor and labor. Obstet Gynecol. 93:1999;987-994.
93. Dong Y.L., Fang L., Kondapaka S., et al. Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy. J Clin Invest. 104:1999;559-565.
94. Grammatopoulos D.K., Hillhouse E.W. Role of corticotropin-releasing hormone in onset of labour. Lancet. 354:1999;1546-1549.
95. Palmier B., Vacher M., Harbon S., Leiber D. A tyrosine kinase signaling pathway, regulated by calcium entry and dissociation from tyrosine phosphorylation of phospholipase Cgamma-1, is involved in inositol phosphate production by activated G protein-coupled receptors in myometrium. J Pharmacol Exp Ther. 289:1999;1022-1030.
96. Sanborn B.M. Relationship of ion channel activity to control of myometrial calcium. J Soc Gynecol Investig. 7:2000;4-11.
97. Slattery M.M., O'Leary M.J., Morrison J.J. Effect of parathyroid hormone-related peptide on human and rat myometrial contractility in vitro. Am J Obstet Gynecol. 184:2000;625-629.
98. Engstrom T. The regulation by ovarian steroids of prostaglandin synthesis and prostaglandin-induced contractility in non-pregnant rat myometrium: modulating effects of isoproterenol. J Endocrinol. 169:2001;33-41.
99. Moran C.J., Friel A.M., Smith T.J., Cairns M., Morrison J.J. Expression and modulation of Rho kinase in human pregnant myometrium. Mol Hum Reprod. 2:2002;196-200.
100. Slattery M.M., Friel A.M., Healy D.G., Morrison J.J. Uterine relaxant effects of cyclooxygenase inhibitors in vitro. Obstet Gynecol. 98:2001;563-569.
101. Dennedy M.C., Friel A.M., Gardeil F., Morrison J.J. Beta-3 versus beta-2 adrenergic agonists and preterm labour: in vitro uterine relaxation effects. BJOG. 108:2001;605-609.
102. Houlihan D.D., Dennedy M.C., Morrison J.J. Polyamine effects on human myometrial contractility. Am J Obstet Gynecol. 186:2002;778-783.
103. Mitchell M.D. The mechanism(s) of human parturition. J Dev Physiol. 6:1984;107-118.
104. Challis J.R.G. Mechanism of parturition and preterm labor. Obstet Gynecol Surv. 55:2000;650-660.
105. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta adrenergic agonist ritodrine. N Engl J Med. 327:1992;308-312.
106. Morrison J.J., Ashford M.L., Khan R.N., Smith S.K. The effects of potassium channel openers on isolated pregnant human myometrium before and after the onset of labor: potential for tocolysis. Am J Obstet Gynecol. 169:1993;1277-1285.
107. Terrone D.A., Rinehart B.K., Kimmel E.S., et al. A prospective randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis. Am J Obstet Gynecol. 182:2000;1477-1482.
108. Bajo A.M., Juarranz M.G., Valenzuela P., et al. Expression of vasoactive intestinal peptide (VIP) receptors in human uterus. Peptides. 21:2000;1383-1388.
109. Hannah M., Amankwah K., Barret J., et al. The Canadian consensus on the use of tocolytics for preterm labour. J SOGC. 17:1995;1089-1115.
110. Gyetvai K., Hannah M.E., Hodnett E.D., Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol. 94:1999;869-877.
111. Lees C.C., Lojacono A., Thompson C., et al. Glyceryl trinitrate and ritodrine in tocolysis: an internation multicenter randomized study. Obstet Gynecol. 94:1999;403-408.
112. Romero R., Sibai B.M., Sanchez-Ramos L., et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol. 182:2000;1173-1183.
113. Abramov Y., Nadjari M., Weinstein D., et al. Indomethacin for preterm labor: a randomized comparison of vaginal and rectal-oral routes. Obstet Gynecol. 95:2000;482-486.
114. Moutquin J.M., Sherman D., Cohen H., et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol. 182:2000;1191-1199.
115. The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG. 108:2001;133-142.
116. Tsatsaris V., Papatsonis D., Goffinet F., Dekker G., Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet Gynecol. 97:2001;840-847.
117. Costeloe K., Hennessy E., Gibson A.T., Marlow N., Wilkinson A.R. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics. 106:2000;659-671.
118. Peruzzi L., Gianoglio B., Porcellini M.G., Coppo R. Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic. Lancet. 354:1999;1615.
119. Slattery M.M., Brennan C., O'Leary M.J., Morrison J.J. Human chorionic gonadotrophin inhibition of pregnant human myometrial contractility. BJOG. 108:2001;704-708.
120. Kurtzman J.T., Spinnato J.A., Goldsmith L.J., et al. Human chorionic gonadotrophin exhibits potent inhibition of preterm delivery in a small animal model. Am J Obstet Gynecol. 181:1999;853-857.
121. Ali A.F.M., Fateen B., Ezzet A., Badawy H., Ramadan A., El-tobge A. Treatment of preterm labor with human chorionic gonadotrophin: a new modality. Obstet Gynecol. 95:(suppl. 1):2000;S61.
122. Crowley P. Prophylactic corticosteroids for preterm birth. The Cochrane Library, Issue 4. 2000;Update Software, Oxford.
123. Goldenberg R.L., Wright L.L. Repeated courses of antenatal corticosteroids. Obstet Gynecol. 97:2001;316-317.
124. Dirnberger D.R., Yoder B.A., Gordon M.C. Single versus repeated-course antenatal corticosteroids: outcomes in singleton and multiple-gestation pregnancies. Am J Perinatol. 18:2001;267-270.
125. Guinn D.A., Atkinson M.W., Sullivan L., et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. JAMA. 286:2001;1581-1587.
126. Kenyon S., Boulvain M. Antibiotics for preterm premature rupture of the membranes. The Cochrane Library, Issue 3. 2000;Oxford Update Software.
127. King J., Flenady V. Antibiotics for preterm labour with intact membranes. The Cochrane Library, Issue 3. 2000;Oxford Update Software.
128. Kenyon S.L., Taylor D.J., Tarnow-Mordi W. Broad spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomized trial. Lancet. 357:2001;989-994.
129. Kenyon S.L., Taylor D.J., Tarnow-Mordi W. Broad spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomized trial. Lancet. 357:2001;979-988.
130. Kurkinen-Raty M., Vuopala S., Koskela M., et al. A randomized controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG. 107:2000;1427-1432.
131. Kekki M., Kurki T., Pelkonen J., et al. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized controlled trial. Obstet Gynecol. 97:2001;643-648.
132. Guise J.M., Mahon S.M., Aickin M., et al. Screening for bacterial vaginosis in pregnancy. Am J Prev Med. 20:(suppl. 3):2001;62-72.
133. Brocklehurst P., Hannah M., McDonald H. Interventions for treating bacterial vaginosis in pregnancy, The Cochrane Library, Issue 2. 2000;Oxford Update Software.
134. Vermeulen G.M., van Zwet A.A., Bruinse H.W. Changes in the vaginal flora after two percent clindamycin vaginal cream in women at high risk of spontaneous preterm birth. BJOG. 108:2001;697-700.
135. MRC/RCOG Working Party on Cervical Cerclage. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomized trial of cervical cerclage. BJOG 1993; 100: 516-23.
136. Rust O.A., Atlas R.O., Jones K.J., Benham B.N., Balducci J. A randomized trial of cerclage versus no cerclage among patients with ultrasonographically detected second-trinester preterm dilatation of the internal os. Am J Obstet Gynecol. 183:2000;830-835.
137. Rust O.A., Atlas R.O., Reed J., van Gaalen J., Balducci J. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am J Obstet Gynecol. 185:2001;1098-1105.
138. Althuisius S.M., Dekker G.A., van Geijn H.P., Bekedam D.J., Hummel P. Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): study design and preliminary results. Am J Obstet Gynecol. 183:2000;823-829.
139. Althuisius S.M., Dekker G.A., Hummel P., Bekedam D.J., van Geijn H.P. Final results of the Cervical Incompetence Prevention Randomized Prevention Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol. 185:2001;1106-1112.
140. Koniak-Griffin D., Anderson N.L., Verzemnieks I., Brecht M.L. A public health nursing early intervention program for adolescent mothers: outcome from pregnancy through 6 weeks postpartum. Nurs Res. 49:2000;130-138.